[
1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3(3):CD004454. doi: 10.1002/14651858. CD004454.pub3.10.1002/14651858
]Search in Google Scholar
[
2. Mori R, Kusuda S, Fujimura M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J Pediatr 2011;159(1):110-14.e1.10.1016/j.jpeds.2010.12.03921334006
]Search in Google Scholar
[
3. Liu SY, Yang HI, Chen CY, Chou HC, Hsieh WS, Tsou KI, et al. The gestational effect of antenatal corticosteroids on respiratory distress syndrome in very low birth weight infants: a population-based study. J Formos Med Assoc 2020;119(8):1267-73. doi: 10.1016/j.jfma.2019.11.002.10.1016/j.jfma.2019.11.00231761503
]Search in Google Scholar
[
4. Kim SM, Sung JH, Kuk JY, Cha HH, Choi SJ, Oh SY, et al. Short- and long-term neonatal outcomes according to differential exposure to antenatal corticosteroid therapy in preterm births prior to 24 weeks of gestation. PLoS One 2018;13(6):e0198471. doi: 10.1371/journal.pone.0198471.10.1371/journal.pone.0198471598611829864169
]Search in Google Scholar
[
5. Romejko-Wolniewicz E, Teliga-Czajkowska J, Czajkowski K. Antenatal steroids: can we optimize the dose? Curr Opin Obstet Gynecol 2014;26(2):77-82.
]Search in Google Scholar
[
6. Wong D, Abdel-Latif ME, Kent AL. 1219 differences in mortality/morbidity with a complete course of antenatal steroids compared to an incomplete/no course in extremely premature neonates. Arch Dis Child 2012;97(Suppl 2):A348-9.10.1136/archdischild-2012-302724.1219
]Search in Google Scholar
[
7. Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, et. al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013;167(12):1102-10.10.1001/jamapediatrics.2013.276424126948
]Search in Google Scholar
[
8. Vogel JP, Oladapo OT, Pileggi-Castro C, Adejuyigbe EA, Althabe F, Ariff S, et al. Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials. BMJ Glob Health 2017;2(3):e000398. doi: 10.1136/bmjgh-2017-000398.10.1136/bmjgh-2017-000398565611929082019
]Search in Google Scholar
[
9. Pilewska-Kozak A, editor. Opieka nad wcześniakiem. Warszawa: Wydawnictwo Lekarskie PZWL; 2009.
]Search in Google Scholar
[
10. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012;(3):CD000510.10.1002/14651858.CD000510.pub222419276
]Search in Google Scholar
[
11. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23(3):305-13.10.1097/MOP.0b013e328346577f376784821494147
]Search in Google Scholar
[
12. Chawla S, Natarajan G, Chowdhury D, Das A, Walsh M, Bell EF, et al. Neonatal morbidities among moderately preterm infants with and without exposure to antenatal corticosteroids. Am J Perinatol 2018;35(12):1213-21.10.1055/s-0038-1642059615693329702710
]Search in Google Scholar
[
13. Jobe AH, Goldenberg RL. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol 2018;219(1):62-74.10.1016/j.ajog.2018.04.00729630886
]Search in Google Scholar
, 